VF
MDCX

Virtu Financial’s Medicus Pharma MDCX Stock Holding History

Virtu Financial’s Portfolio MDCX Stock Details MDCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-74,045
Closed -$34K – 2385
2026
Q1 		$34K Buy
+74,045
New +$77.3K ﹤0.01% 1339

Other funds holding MDCX

ICP
Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $479M AUM 31.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return

Virtu Financial's MDCX Position: Q2 2026 in Review

Virtu Financial sold out of Medicus Pharma (MDCX) in Q2 2026, closing a stake of 74,045 shares — an estimated $34K sold.

Virtu Financial first reported a position in MDCX in Q1 2026 and held it in 1 quarter. The position peaked at $34K in Q1 2026. 23 funds tracked by Wall St. Rank hold MDCX as of Q2 2026.

  • Virtu Financial reported no remaining Medicus Pharma position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 74,045 Medicus Pharma shares in Q2 2026, an estimated $34K.
  • Virtu Financial first reported a position in Medicus Pharma in Q1 2026 and held it in 1 quarter.
  • Virtu Financial's Medicus Pharma position peaked at $34K in Q1 2026.
  • 23 funds tracked by Wall St. Rank held Medicus Pharma as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.